colchicine has been researched along with 2019 Novel Coronavirus Disease in 123 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 123 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmad, R; Archer, H; Cambi, B; Cleman, M; Dela Cruz, CS; Howes, C; Kandel, P; Kashyap, N; Khan, M; Kluger, J; Lancaster, G; Lansky, A; Lu, J; McCarthy, M; Nasir, I; Paredes, C; Parise, H; Patel, P; Ragheb, E; Shah, T; Song, C; Ul Haq, F | 1 |
| Alconero, LL; Cacho, PM; Caro, JCL; Espiga, CR; Estebanez, EB; Fernández, BJ; Marguello, MG; Saiz, MMG; Sampedro, MF; Vallejo, JD | 1 |
| Amarillo, M; Arias Arias, C; Betancur, JF; Cardona Arango, D; Holguín, H; Llano, JF; Montoya, P; Muñoz Palacio, BJ; Ortiz, S; Pinzón, MA | 1 |
| Abdeen, S; Abu-Fanne, R; Bdeir, K; Cines, DB; Heyman, SN; Higazi, AA; Higazi, M; Maraga, E | 1 |
| Basiak, M; Filipiak, KJ; Okopień, B; Romańczyk, M; Surma, S | 1 |
| Schattner, A | 1 |
| Becker, M; Dorando, E; Fischer, AL; Martimbianco, ALC; Metzendorf, MI; Mikolajewska, A; Mueller, A; Pacheco, RL; Piechotta, V; Riera, R; Skoetz, N; Stegemann, M | 2 |
| Gómez-López, A; Parra-Medina, R; Rojas-Villarraga, A | 1 |
| Alunno, A; Carubbi, F; Cicogna, S; Del Pinto, R; Di Gregorio, N; Ferri, C; Grassi, D; Leone, S; Mancini, B; Viscido, A | 1 |
| Ali, Z; Cherrez-Ojeda, I; Fatima, M; Sarfraz, A; Sarfraz, Z; Sarwar, M | 1 |
| Erol, Ç | 1 |
| Chavda, PD; Mehta, KG; Patel, P; Patel, T | 1 |
| Doumas, M; Karagiannis, A; Papadopoulos, C; Patoulias, D | 1 |
| Baeza-Román, A; De-Miguel-Balsa, E; Estevan-Ortega, R; Latour-Pérez, J; Moya-Martinez, A; Ramos-Rincon, JM; Sempere-Selva, MT | 1 |
| Atalay, E; Balık, Z; Basaran, O; Batu, ED; Bilginer, Y; Cuceoglu, MK; Gurlevik, S; Kaya Akca, U; Oygar, PD; Ozen, S; Ozsurekci, Y; Sener, S; Teksam, O | 1 |
| Aggarwal, R; Chiu, L; Chiu, N; Choi, YG; Chow, R; Lam, H; Lee, J; Lo, CH; Prsic, EH; Shen, M; Shin, HJ | 1 |
| Bhatt, DL; Botto, F; Caccavo, A; Castellana, N; Chacón, C; Corral, G; Corral, P; Díaz, ML; Diaz, R; Domínguez, JM; Eikelboom, J; Galatte, A; Gutierrez, O; Jolly, SS; Lamelas, P; Loeb, M; Maggioni, AP; Miró, JM; Orlandini, A; Pascual, A; Rovito, C; Scarafia, F; Sued, O; Yusuf, S | 1 |
| Goh, HP; Hasan, SS; Kow, CS; Lee, LH; Ming, LC; Ramachandram, DS | 1 |
| Bussolati, B; Camussi, G; Deregibus, MC; Grange, C; Peruzzi, L; Skovronova, R; Tanzi, A; Verta, R | 1 |
| Brockman, T; Hernandez, L; Mehta, T; Thapa, B | 1 |
| Callejas-Rubio, JL; Correa-Rodríguez, M; Hera-Fernández, J; Ortego-Centeno, N; Ríos-Fernández, R; Rueda-Medina, B | 1 |
| Ghosh, S; Handa, N; Panda, P; Sharma, YP | 1 |
| Raffaello, WM; Zein, AFMZ | 1 |
| Abedini, A; Akhoundi Meybodi, Z; Eidani, E; Gholinataj Jelodar, M; Gholmzadeh Baeis, M; Habtemariam, S; Kiani, A; Mousavinasab, SR; Movaseghi, F; Mozafari, A; Nabi Meybodi, M; Pourdowlat, G; Raji, H; Sadeghi Yakhdani, A; Saghafi, F; Sahebnasagh, A; Salehi Nezamabadi, A; Soltani, N | 1 |
| Abbate, A; Bonaventura, A; Dagna, L; Dentali, F; Tangianu, F; Vecchié, A | 1 |
| Al-Gareeb, AI; Al-Kuraishy, HM; Al-Niemi, MS; Hussien, NR | 1 |
| Belli, S; Caruso, F; Florea, RM; Incerpi, S; Kaur, S; Pedersen, JZ; Rossi, M | 1 |
| Armağan, B; Ateş, İ; Erden, A; Gemcioglu, E; Güven, SC; Inan, O; Karakaş, Ö; Küçüksahin, O; Kurtipek, AC; Omma, A; Sahiner, ES | 1 |
| Casey, A; Kennedy, M; McAdam, B; Quinn, S; Sheahan, R | 1 |
| Dalbeth, N; He, Y; Hu, S; Li, C; Li, X; Lu, J; Ran, Z; Shi, Y; Sun, M; Terkeltaub, R; Wang, C; Xu, X; Xue, X; Yan, F; Yin, H; Zhang, H | 1 |
| Akyüz Dağlı, P; Armağan, B; Atalar, E; Doğan, İ; Erden, A; Erten, Ş; Gök, K; Güven, SC; Karakaş, Ö; Kayacan Erdoğan, E; Konak, HE; Küçükşahin, O; Maraş, Y; Omma, A | 1 |
| Alejandre de Oña, A; Alfonso, F; Alfranca, A; Ancochea, J; Ávalos, E; Barrios, A; Bautista-Hernández, A; Caballero, P; Cecconi, A; Cecconi, M; Ciudad, M; de La Fuente, H; Fernandez Carracedo, E; Fernandez-Madera Martínez, R; Fonseca Aizpuru, E; García Castillo, E; Hernandez Muñiz, S; Iturricastillo, G; Jimenez-Borreguero, LJ; Lavilla Olleros, C; Marcos-Jimenez, A; Martinez-Vives, P; Olivera, MJ; Pampin Sanchez, R; Prada Cotado, D; Roquero, P; Sanchez-Madrid, F; Sanz de Benito, MA; Sanz-Garcia, A; Suarez, C; Vera, A | 1 |
| Concepción Carrillo, LE; Iturbe Esquivel, B; Mendieta Zeron, H; Meneses Calderón, J | 1 |
| Caporilli, C; Esposito, S; Marinelli, F; Rigante, D; Titolo, A | 1 |
| Elliott, JH; Henry, D; Pearson, SA; Schaffer, AL; Zoega, H | 1 |
| Bazid, Z; Brem, FL; Ismaili, N; Mir, ZE; Ouafi, NE; Rasras, H | 1 |
| Avanoglu Guler, A; Bilici, R; Coskun, C; Goker, B; Haznedaroglu, S; Karadeniz, H; Kasifoglu, T; Kucuk, H; Ozturk, MA; Sari, I; Satis, H; Tufan, A; Yildirim, D; Yuce Inel, T | 1 |
| Amaral De Sousa, CR; Basbus, L; Callegari, MS; Cayol, F; Manganiello, CF; Porta, RE | 1 |
| Ali, Z; Anand, SS; Avezum, A; Bangdiwala, SI; Belley-Cote, EP; Berwanger, O; Bosch, J; Choudhri, S; Dans, AL; Eikelboom, JW; Farkouh, ME; Felix, C; Harper, W; Hassany, M; Heenan, L; Jolly, SS; Kontsevaya, A; Loeb, M; Lopes, RD; Lopez-Jaramillo, P; Pais, P; Palileo-Villanueva, LM; Rangarajan, S; Sharma, SK; Tarhuni, WM; Wasserman, S; Whitlock, RP; Xavier, D; Xu, L; Yusuf, S; Yusufali, A | 1 |
| Chen, J; Cheng, Q; Fang, Z; Jia, Q; Zhao, G | 1 |
| Andreoni, M; Bartoloni, E; Becattini, C; Brucato, A; Cingolani, A; Cutolo, M; Gerli, R; Perricone, C; Pigatto, E; Pisano, P; Poletti, V; Prota, R; Rozza, D; Scarsi, M; Tardella, M; Tiso, F; Tomasoni, LR; Zerbino, C | 1 |
| Akcan, MB; Albuz, B; Ozdemir, O; Silan, F | 1 |
| Finsterer, J | 1 |
| Agapov, МA; Akopyan, ZA; Asratyan, DA; Begrambekova, YL; Dyachuk, LI; Kamalov, AA; Krasnova, TN; Malahov, PS; Mareev, VY; Mareev, YV; Matskeplishvili, ST; Mershina, EM; Orlova, YA; Pavlikova, EP; Plisuk, AG; Potapenko, AV; Samokhodskaya, LM; Seredenina, EM; Shatokhina, EA; Sinitsyn, VE | 1 |
| Figueiras, A; Herdeiro, MT; Piñeiro-Lamas, M; Portela-Romero, M; Sáenz-Aldea, M; Saez, M; Salgado-Barreira, Á; Taracido Trunk, M | 1 |
| Ghazaeian, M; Ghazaiean, M; Ghodssi-Ghassemabadi, R; Kasiri, H; Naderi-Behdani, F; Rouhani, N | 1 |
| Schectman, JM | 1 |
| Alyaarabi, T; Danjuma, MI; Elsayed, B; Elshafei, M; Kaul, R | 1 |
| Ahmad, R; Archer, H; Cambi, B; Cleman, M; Dela Cruz, C; Howes, C; Huang, H; Kandel, P; Kashyap, N; Khan, M; Kluger, J; Lancaster, G; Lansky, A; Lu, J; McCarthy, M; Nasir, I; Paredes, C; Parise, H; Patel, P; Ragheb, E; Shah, T; Song, C; Ul Haq, F | 1 |
| Almeida, SCL; Alves-Filho, JC; Amaral, NB; Arruda, E; Auxiliadora-Martins, M; Benatti, MN; Bollela, VR; Bonjorno, LP; Borges, MC; Cunha, FQ; Cunha, LD; Cunha, TM; Del-Ben, CM; Dib, SM; Emrich-Filho, LL; Fonseca, BAL; Giannini, MC; Gigante, SLG; Leiria, LOS; Lopes, MI; Louzada-Junior, P; Luppino-Assad, R; Menezes, PISO; Miranda, CH; Oliveira, RDR; Pazin-Filho, A; Rezek, UC; Rodrigues, TS; Santana, RC; Schneider, AH; Sousa, BA; Veras, FP; Vilar, FC; Zamboni, DS | 1 |
| Chang, HC; Gau, SY | 1 |
| Agati, LB; Aguiar, VCR; Bellissimo-Rodrigues, F; Bonifácio, LP; Dusilek, C; Ferreira, LRR; Fonseca, BALD; Itinose, K; Kallas, EG; Lopes, RD; Louzada Júnior, P; Oliveira, CCC; Quadros, CAA; Ramacciotti, E; Risson, R; Silva, ACTD; Souza, HCC; Vilar, FC | 1 |
| Figueiras, A; Herdeiro, MT; Piñeiro-Lamas, M; Portela-Romero, M; Sáenz-Aldea, M; Saez, M; Salgado-Barreira, Á; Taracido-Trunk, M | 1 |
| Dhiver, C; Dudouet, P; Gautret, P; Nguyen, NN | 1 |
| Fiegen, N; Malik, MN; Petrasko, M; Saad Shaukat, MH | 1 |
| Bonacchini, L; Camponovo, C; Frigoli, E; Landi, A; Moccetti, T; Morici, N; Omazzi, B; Tresoldi, M; Valgimigli, M; Vranckx, P | 1 |
| Cravedi, P; Degli Antoni, A; Delsante, M; Fiaccadori, E; Gandolfini, I; Maggiore, U; Manenti, L; Peruzzi, L; Riella, LV; Zaza, G | 1 |
| Cleman, M; Dangas, G; Deftereos, S; Giannopoulos, G; Giotaki, SG; Siasos, G; Stefanadis, C; Vrachatis, DA | 1 |
| Altschuler, EL; Kast, RE | 1 |
| Bettiol, A; Di Scala, G; Emmi, G; Mattioli, I; Prisco, D; Silvestri, E; Urban, ML; Vaglio, A | 1 |
| Amital, H; Bragazzi, NL; Chodick, G; Gendelman, O; Watad, A | 1 |
| Cumhur Cure, M; Cure, E; Kucuk, A | 1 |
| Farasatinasab, M; Nasiripour, S; Zamani, F | 1 |
| Apps, R; Chen, J; Cheung, FK; Demidowich, AP; Fantoni, G; Levine, JA; Patel, TP; Yanovski, JA | 1 |
| Andreoli, L; Franceschini, F; Furloni, R; Patroni, A; Piantoni, S; Scarsi, M; Toniati, P | 1 |
| Dagna, L; Della-Torre, E; Della-Torre, F; Kusanovic, M; Ramirez, GA; Scotti, R; Tresoldi, M | 1 |
| Dalili, N; Fatemizadeh, S; Firouzan, A; Kashefizadeh, A; Nafar, M; Poorrezagholi, F; Samadian, F; Samavat, S; Ziaie, S | 1 |
| Andreou, A; Filippou, D; Sipsas, N; Trantza, S; Tsiodras, S | 1 |
| Kobak, S | 2 |
| Montecucco, C; Monti, S | 1 |
| Corral, G; Corral, P; Diaz, R | 1 |
| Garavito, E; Gómez-López, A; Montealegre-Gómez, G; Parra-Medina, R; Rojas-Villarraga, A; Sarmiento-Monroy, JC | 1 |
| Airò, P; Andreoli, L; Brucato, A; Colombo, E; Franceschini, F; Furloni, R; Piantoni, S; Scarsi, M; Tincani, A | 1 |
| Parikh, RV; Rabbani, AB; Rafique, AM | 1 |
| Alexopoulos, D; Angelidis, C; Baltagiannis, S; Cleman, M; Dangas, G; Davlouros, P; Deftereos, SG; Dolianitis, K; Gargalianos, P; Gerakari, S; Giannopoulos, G; Giotaki, SG; Gogos, C; Goudevenos, J; Hahalis, G; Iliodromitis, E; Kanonidis, I; Katritsis, D; Kolettis, T; Kotanidou, A; Koulouris, NG; Manolis, AS; Martinèz-Dolz, L; Mehran, R; Metallidis, S; Michalis, L; Migdalis, I; Milionis, H; Naka, KK; Olympios, CD; Panagopoulos, P; Pyrgakis, VN; Randou, E; Reimers, B; Sianos, G; Siasos, GD; Sipsas, N; Stefanadis, C; Stefanini, GG; Syrigos, K; Tousoulis, D; Toutouzas, KP; Triposkiadis, F; Tsagalou, E; Tsiodras, S; Tsioufis, K; Tsoukalas, G; Vavouranakis, E; Vrachatis, DA | 1 |
| Barbagallo, T; Fantini, F; Franzetti, M; Piconi, S; Prestinari, F; Recalcati, S | 1 |
| Mansouri, D; Mansouri, N; Marjani, M; Tabarsi, P; von Garnier, C | 1 |
| Adler, Y; Andreis, A; Brucato, A; De Ferrari, GM; Imazio, M; Klein, A; Lazaros, G; Scarsi, M | 1 |
| Adrovic, A; Aliyeva, A; Barut, K; Haslak, F; Kasapcopur, O; Koker, O; Sahin, S; Yildiz, M | 1 |
| Airó, P; Andreoli, L; Bertasi, V; Bianchi, M; Bottone, D; Brucato, A; Civelli, P; Colombo, E; Cotelli, MS; Damiolini, E; Franceschini, F; Furloni, R; Galbassini, G; Gatta, D; Ghirardelli, ML; Magri, R; Malamani, P; Mendeni, M; Miclini, M; Molinari, S; Morotti, A; Piantoni, S; Richini, D; Salada, L; Scarsi, M; Tincani, A; Turla, M; Vender, A | 1 |
| Arias-Santiago, S; Cuenca-Barrales, C; Martinez-Lopez, A; Molina-Leyva, A; Montero-Vilchez, T | 1 |
| Abbasi, S; Abd El-Wahab, A; Abdallah, M; Abebe, G; Aca-Aca, G; Adama, S; Adefegha, SA; Adidigue-Ndiome, R; Adiseshaiah, P; Adrario, E; Aghajanian, C; Agnese, W; Ahmad, A; Ahmad, I; Ahmed, MFE; Akcay, OF; Akinmoladun, AC; Akutagawa, T; Alakavuklar, MA; Álava-Rabasa, S; Albaladejo-Florín, MJ; Alexandra, AJE; Alfawares, R; Alferiev, IS; Alghamdi, HS; Ali, I; Allard, B; Allen, JD; Almada, E; Alobaid, A; Alonso, GL; Alqahtani, YS; Alqarawi, W; Alsaleh, H; Alyami, BA; Amaral, BPD; Amaro, JT; Amin, SAW; Amodio, E; Amoo, ZA; Andia Biraro, I; Angiolella, L; Anheyer, D; Anlay, DZ; Annex, BH; Antonio-Aguirre, B; Apple, S; Arbuznikov, AV; Arinsoy, T; Armstrong, DK; Ash, S; Aslam, M; Asrie, F; Astur, DC; Atzrodt, J; Au, DW; Aucoin, M; Auerbach, EJ; Azarian, S; Ba, D; Bai, Z; Baisch, PRM; Balkissou, AD; Baltzopoulos, V; Banaszewski, M; Banerjee, S; Bao, Y; Baradwan, A; Barandika, JF; Barger, PM; Barion, MRL; Barrett, CD; Basudan, AM; Baur, LE; Baz-Rodríguez, SA; Beamer, P; Beaulant, A; Becker, DF; Beckers, C; Bedel, J; Bedlack, R; Bermúdez de Castro, JM; Berry, JD; Berthier, C; Bhattacharya, D; Biadgo, B; Bianco, G; Bianco, M; Bibi, S; Bigliardi, AP; Billheimer, D; Birnie, DH; Biswas, K; Blair, HC; Bognetti, P; Bolan, PJ; Bolla, JR; Bolze, A; Bonnaillie, P; Borlimi, R; Bórquez, J; Bottari, NB; Boulleys-Nana, JR; Brighetti, G; Brodeur, GM; Budnyak, T; Budnyk, S; Bukirwa, VD; Bulman, DM; Burm, R; Busman-Sahay, K; Butcher, TW; Cai, C; Cai, H; Cai, L; Cairati, M; Calvano, CD; Camacho-Ordóñez, A; Camela, E; Cameron, T; Campbell, BS; Cansian, RL; Cao, Y; Caporale, AS; Carciofi, AC; Cardozo, V; Carè, J; Carlos, AF; Carozza, R; Carroll, CJW; Carsetti, A; Carubelli, V; Casarotta, E; Casas, M; Caselli, G; Castillo-Lora, J; Cataldi, TRI; Cavalcante, ELB; Cavaleiro, A; Cayci, Z; Cebrián-Tarancón, C; Cedrone, E; Cella, D; Cereda, C; Ceretti, A; Ceroni, M; Cha, YH; Chai, X; Chang, EF; Chang, TS; Chanteux, H; Chao, M; Chaplin, BP; Chaturvedi, S; Chaturvedi, V; Chaudhary, DK; Chen, A; Chen, C; Chen, HY; Chen, J; Chen, JJ; Chen, K; Chen, L; Chen, Q; Chen, R; Chen, SY; Chen, TY; Chen, WM; Chen, X; Chen, Y; Cheng, G; Cheng, GJ; Cheng, J; Cheng, YH; Cheon, HG; Chew, KW; Chhoker, S; Chiu, WN; Choi, ES; Choi, MJ; Choi, SD; Chokshi, S; Chorny, M; Chu, KI; Chu, WJ; Church, AL; Cirrincione, A; Clamp, AR; Cleff, MB; Cohen, M; Coleman, RL; Collins, SL; Colombo, N; Conduit, N; Cong, WL; Connelly, MA; Connor, J; Cooley, K; Correa Ramos Leal, I; Cose, S; Costantino, C; Cottrell, M; Cui, L; Cundall, J; Cutaia, C; Cutler, CW; Cuypers, ML; da Silva Júnior, FMR; Dahal, RH; Damiani, E; Damtie, D; Dan-Li, W; Dang, Z; Dasa, SSK; Davin, A; Davis, DR; de Andrade, CM; de Jong, PL; de Oliveira, D; de Paula Dorigam, JC; Dean, A; Deepa, M; Delatour, C; Dell'Aiera, S; Delley, MF; den Boer, RB; Deng, L; Deng, Q; Depner, RM; Derdau, V; Derici, U; DeSantis, AJ; Desmarini, D; Diffo-Sonkoue, L; Divizia, M; Djenabou, A; Djordjevic, JT; Dobrovolskaia, MA; Domizi, R; Donati, A; Dong, Y; Dos Santos, M; Dos Santos, MP; Douglas, RG; Duarte, PF; Dullaart, RPF; Duscha, BD; Edwards, LA; Edwards, TE; Eichenwald, EC; El-Baba, TJ; Elashiry, M; Elashiry, MM; Elashry, SH; Elliott, A; Elsayed, R; Emerson, MS; Emmanuel, YO; Emory, TH; Endale-Mangamba, LM; Enten, GA; Estefanía-Fernández, K; Estes, JD; Estrada-Mena, FJ; Evans, S; Ezra, L; Faria de, RO; Farraj, AK; Favre, C; Feng, B; Feng, J; Feng, L; Feng, W; Feng, X; Feng, Z; Fernandes, CLF; Fernández-Cuadros, ME; Fernie, AR; Ferrari, D; Florindo, PR; Fong, PC; Fontes, EPB; Fontinha, D; Fornari, VJ; Fox, NP; Fu, Q; Fujitaka, Y; Fukuhara, K; Fumeaux, T; Fuqua, C; Fustinoni, S; Gabbanelli, V; Gaikwad, S; Gall, ET; Galli, A; Gancedo, MA; Gandhi, MM; Gao, D; Gao, K; Gao, M; Gao, Q; Gao, X; Gao, Y; Gaponenko, V; Garber, A; Garcia, EM; García-Campos, C; García-Donas, J; García-Pérez, AL; Gasparri, F; Ge, C; Ge, D; Ge, JB; Ge, X; George, I; George, LA; Germani, G; Ghassemi Tabrizi, S; Gibon, Y; Gillent, E; Gillies, RS; Gilmour, MI; Goble, S; Goh, JC; Goiri, F; Goldfinger, LE; Golian, M; Gómez, MA; Gonçalves, J; Góngora-García, OR; Gonul, I; González, MA; Govers, TM; Grant, PC; Gray, EH; Gray, JE; Green, MS; Greenwald, I; Gregory, MJ; Gretzke, D; Griffin-Nolan, RJ; Griffith, DC; Gruppen, EG; Guaita, A; Guan, P; Guan, X; Guerci, P; Guerrero, DT; Guo, M; Guo, P; Guo, R; Guo, X; Gupta, J; Guz, G; Hajizadeh, N; Hamada, H; Haman-Wabi, AB; Han, TT; Hannan, N; Hao, S; Harjola, VP; Harmon, M; Hartmann, MSM; Hartwig, JF; Hasani, M; Hawthorne, WJ; Haykal-Coates, N; Hazari, MS; He, DL; He, P; He, SG; Héau, C; Hebbar Kannur, K; Helvaci, O; Heuberger, DM; Hidalgo, F; Hilty, MP; Hirata, K; Hirsch, A; Hoffman, AM; Hoffmann, JF; Holloway, RW; Holmes, RK; Hong, S; Hongisto, M; Hopf, NB; Hörlein, R; Hoshino, N; Hou, Y; Hoven, NF; Hsieh, YY; Hsu, CT; Hu, CW; Hu, JH; Hu, MY; Hu, Y; Hu, Z; Huang, C; Huang, D; Huang, DQ; Huang, L; Huang, Q; Huang, R; Huang, S; Huang, SC; Huang, W; Huang, Y; Huffman, KM; Hung, CH; Hung, CT; Huurman, R; Hwang, SM; Hyun, S; Ibrahim, AM; Iddi-Faical, A; Immordino, P; Isla, MI; Jacquemond, V; Jacques, T; Jankowska, E; Jansen, JA; Jäntti, T; Jaque-Fernandez, F; Jarvis, GA; Jatt, LP; Jeon, JW; Jeong, SH; Jhunjhunwala, R; Ji, F; Jia, X; Jia, Y; Jian-Bo, Z; Jiang, GD; Jiang, L; Jiang, W; Jiang, WD; Jiang, Z; Jiménez-Hoyos, CA; Jin, S; Jobling, MG; John, CM; John, T; Johnson, CB; Jones, KI; Jones, WS; Joseph, OO; Ju, C; Judeinstein, P; Junges, A; Junnarkar, M; Jurkko, R; Kaleka, CC; Kamath, AV; Kang, X; Kantsadi, AL; Kapoor, M; Karim, Z; Kashuba, ADM; Kassa, E; Kasztura, M; Kataja, A; Katoh, T; Kaufman, JS; Kaupp, M; Kehinde, O; Kehrenberg, C; Kemper, N; Kerr, CW; Khan, AU; Khan, MF; Khan, ZUH; Khojasteh, SC; Kilburn, S; Kim, CG; Kim, DU; Kim, DY; Kim, HJ; Kim, J; Kim, OH; Kim, YH; King, C; Klein, A; Klingler, L; Knapp, AK; Ko, TK; Kodavanti, UP; Kolla, V; Kong, L; Kong, RY; Kong, X; Kore, S; Kortz, U; Korucu, B; Kovacs, A; Krahnert, I; Kraus, WE; Kuang, SY; Kuehn-Hajder, JE; Kurz, M; Kuśtrowski, P; Kwak, YD; Kyttaris, VC; Laga, SM; Laguerre, A; Laloo, A; Langaro, MC; Langham, MC; Lao, X; Larocca, MC; Lassus, J; Lattimer, TA; Lazar, S; Le, MH; Leal, DB; Leal, M; Leary, A; Ledermann, JA; Lee, JF; Lee, MV; Lee, NH; Leeds, CM; Leeds, JS; Lefrandt, JD; Leicht, AS; Leonard, M; Lev, S; Levy, K; Li, B; Li, C; Li, CM; Li, DH; Li, H; Li, J; Li, L; Li, LJ; Li, N; Li, P; Li, T; Li, X; Li, XH; Li, XQ; Li, XX; Li, Y; Li, Z; Li, ZY; Liao, YF; Lin, CC; Lin, MH; Lin, Y; Ling, Y; Links, TP; Lira-Romero, E; Liu, C; Liu, D; Liu, H; Liu, J; Liu, L; Liu, LP; Liu, M; Liu, T; Liu, W; Liu, X; Liu, XH; Liu, Y; Liuwantara, D; Ljumanovic, N; Lobo, L; Lokhande, K; Lopes, A; Lopes, RMRM; López-Gutiérrez, JC; López-Muñoz, MJ; López-Santamaría, M; Lorenzo, C; Lorusso, D; Losito, I; Lu, C; Lu, H; Lu, HZ; Lu, SH; Lu, SN; Lu, Y; Lu, ZY; Luboga, F; Luo, JJ; Luo, KL; Luo, Y; Lutomski, CA; Lv, W; M Piedade, MF; Ma, J; Ma, JQ; Ma, JX; Ma, N; Ma, P; Ma, S; Maciel, M; Madureira, M; Maganaris, C; Maginn, EJ; Mahnashi, MH; Maierhofer, M; Majetschak, M; Malla, TR; Maloney, L; Mann, DL; Mansuri, A; Marelli, E; Margulis, CJ; Marrella, A; Martin, BL; Martín-Francés, L; Martínez de Pinillos, M; Martínez-Navarro, EM; Martinez-Quintanilla Jimenez, D; Martínez-Velasco, A; Martínez-Villaseñor, L; Martinón-Torres, M; Martins, BA; Massongo, M; Mathew, AP; Mathews, D; Matsui, J; Matsumoto, KI; Mau, T; Maves, RC; Mayclin, SJ; Mayer, JM; Maynard, ND; Mayr, T; Mboowa, MG; McEvoy, MP; McIntyre, RC; McKay, JA; McPhail, MJW; McVeigh, AL; Mebazaa, A; Medici, V; Medina, DN; Mehmood, T; Mei-Li, C; Melku, M; Meloncelli, S; Mendes, GC; Mendoza-Velásquez, C; Mercadante, R; Mercado, MI; Merenda, MEZ; Meunier, J; Mi, SL; Michels, M; Mijatovic, V; Mikhailov, V; Milheiro, SA; Miller, DC; Ming, F; Mitsuishi, M; Miyashita, T; Mo, J; Mo, S; Modesto-Mata, M; Moeller, S; Monte, A; Monteiro, L; Montomoli, J; Moore, EE; Moore, HB; Moore, PK; Mor, MK; Moratalla-López, N; Moratilla Lapeña, L; Moreira, R; Moreno, MA; Mörk, AC; Morton, M; Mosier, JM; Mou, LH; Mougharbel, AS; Muccillo-Baisch, AL; Muñoz-Serrano, AJ; Mustafa, B; Nair, GM; Nakanishi, I; Nakanjako, D; Naraparaju, K; Nawani, N; Neffati, R; Neil, EC; Neilipovitz, D; Neira-Borrajo, I; Nelson, MT; Nery, PB; Nese, M; Nguyen, F; Nguyen, MH; Niazy, AA; Nicolaï, J; Nogueira, F; Norbäck, D; Novaretti, JV; O'Donnell, T; O'Dowd, A; O'Malley, DM; Oaknin, A; Ogata, K; Ohkubo, K; Ojha, M; Olaleye, MT; Olawande, B; Olomo, EJ; Ong, EWY; Ono, A; Onwumere, J; Ortiz Bibriesca, DM; Ou, X; Oza, AM; Ozturk, K; Özütemiz, C; Palacio-Pastrana, C; Palaparthi, A; Palevsky, PM; Pan, K; Pantanetti, S; Papachristou, DJ; Pariani, A; Parikh, CR; Parissis, J; Paroul, N; Parry, S; Patel, N; Patel, SM; Patel, VC; Pawar, S; Pefura-Yone, EW; Peixoto Andrade, BCO; Pelepenko, LE; Peña-Lora, D; Peng, S; Pérez-Moro, OS; Perez-Ortiz, AC; Perry, LM; Peter, CM; Phillips, NJ; Phillips, P; Pia Tek, J; Piner, LW; Pinto, EA; Pinto, SN; Piyachaturawat, P; Poka-Mayap, V; Polledri, E; Poloni, TE; Ponessa, G; Poole, ST; Post, AK; Potter, TM; Pressly, BB; Prouty, MG; Prudêncio, M; Pulkki, K; Pupier, C; Qian, H; Qian, ZP; Qiu, Y; Qu, G; Rahimi, S; Rahman, AU; Ramadan, H; Ramanna, S; Ramirez, I; Randolph, GJ; Rasheed, A; Rault, J; Raviprakash, V; Reale, E; Redpath, C; Rema, V; Remucal, CK; Remy, D; Ren, T; Ribeiro, LB; Riboli, G; Richards, J; Rieger, V; Rieusset, J; Riva, A; Rivabella Maknis, T; Robbins, JL; Robinson, CV; Roche-Campo, F; Rodriguez, R; Rodríguez-de-Cía, J; Rollenhagen, JE; Rosen, EP; Rub, D; Rubin, N; Rubin, NT; Ruurda, JP; Saad, O; Sabell, T; Saber, SE; Sabet, M; Sadek, MM; Saejio, A; Salinas, RM; Saliu, IO; Sande, D; Sang, D; Sangenito, LS; Santos, ALSD; Sarmiento Caldas, MC; Sassaroli, S; Sassi, V; Sato, J; Sauaia, A; Saunders, K; Saunders, PR; Savarino, SJ; Scambia, G; Scanlon, N; Schetinger, MR; Schinkel, AFL; Schladweiler, MC; Schofield, CJ; Schuepbach, RA; Schulz, J; Schwartz, N; Scorcella, C; Seeley, J; Seemann, F; Seinige, D; Sengoku, T; Seravalli, J; Sgromo, B; Shaheen, MY; Shan, L; Shanmugam, S; Shao, H; Sharma, S; Shaw, KJ; Shen, BQ; Shen, CH; Shen, P; Shen, S; Shen, Y; Shen, Z; Shi, J; Shi-Li, L; Shimoda, K; Shoji, Y; Shun, C; Silva, MA; Silva-Cardoso, J; Simas, NK; Simirgiotis, MJ; Sincock, SA; Singh, MP; Sionis, A; Siu, J; Sivieri, EM; Sjerps, MJ; Skoczen, SL; Slabon, A; Slette, IJ; Smith, MD; Smith, S; Smith, TG; Snapp, KS; Snow, SJ; Soares, MCF; Soberman, D; Solares, MD; Soliman, I; Song, J; Sorooshian, A; Sorrell, TC; Spinar, J; Staudt, A; Steinhart, C; Stern, ST; Stevens, DM; Stiers, KM; Stimming, U; Su, YG; Subbian, V; Suga, H; Sukhija-Cohen, A; Suksamrarn, A; Suksen, K; Sun, J; Sun, M; Sun, P; Sun, W; Sun, XF; Sun, Y; Sundell, J; Susan, LF; Sutjarit, N; Swamy, KV; Swisher, EM; Sykes, C; Takahashi, JA; Talmor, DS; Tan, B; Tan, ZK; Tang, L; Tang, S; Tanner, JJ; Tanwar, M; Tarazi, Z; Tarvasmäki, T; Tay, FR; Teketel, A; Temitayo, GI; Thersleff, T; Thiessen Philbrook, H; Thompson, LC; Thongon, N; Tian, B; Tian, F; Tian, Q; Timothy, AT; Tingle, MD; Titze, IR; Tolppanen, H; Tong, W; Toyoda, H; Tronconi, L; Tseng, CH; Tu, H; Tu, YJ; Tung, SY; Turpault, S; Tuynman, JB; Uemoto, AT; Ugurlu, M; Ullah, S; Underwood, RS; Ungell, AL; Usandizaga-Elio, I; Vakonakis, I; van Boxel, GI; van den Beucken, JJJP; van der Boom, T; van Slegtenhorst, MA; Vanni, JR; Vaquera, A; Vasconcellos, RS; Velayos, M; Vena, R; Ventura, G; Verso, MG; Vincent, RP; Vitale, F; Vitali, S; Vlek, SL; Vleugels, MPH; Volkmann, N; Vukelic, M; Wagner Mackenzie, B; Wairagala, P; Waller, SB; Wan, J; Wan, MT; Wan, Y; Wang, CC; Wang, H; Wang, J; Wang, JF; Wang, K; Wang, L; Wang, M; Wang, S; Wang, WM; Wang, X; Wang, Y; Wang, YD; Wang, YF; Wang, Z; Wang, ZG; Warriner, K; Weberpals, JI; Weerachayaphorn, J; Wehrli, FW; Wei, J; Wei, KL; Weinheimer, CJ; Weisbord, SD; Wen, S; Wendel Garcia, PD; Williams, JW; Williams, R; Winkler, C; Wirman, AP; Wong, S; Woods, CM; Wu, B; Wu, C; Wu, F; Wu, P; Wu, S; Wu, Y; Wu, YN; Wu, ZH; Wurtzel, JGT; Xia, L; Xia, Z; Xia, ZZ; Xiao, H; Xie, C; Xin, ZM; Xing, Y; Xing, Z; Xu, S; Xu, SB; Xu, T; Xu, X; Xu, Y; Xue, L; Xun, J; Yaffe, MB; Yalew, A; Yamamoto, S; Yan, D; Yan, H; Yan, S; Yan, X; Yang, AD; Yang, E; Yang, H; Yang, J; Yang, JL; Yang, K; Yang, M; Yang, P; Yang, Q; Yang, S; Yang, W; Yang, X; Yang, Y; Yao, JC; Yao, WL; Yao, Y; Yaqub, TB; Ye, J; Ye, W; Yen, CW; Yeter, HH; Yin, C; Yip, V; Yong-Yi, J; Yu, HJ; Yu, MF; Yu, S; Yu, W; Yu, WW; Yu, X; Yuan, P; Yuan, Q; Yue, XY; Zaia, AA; Zakhary, SY; Zalwango, F; Zamalloa, A; Zamparo, P; Zampini, IC; Zani, JL; Zeitoun, R; Zeng, N; Zenteno, JC; Zepeda-Palacio, C; Zhai, C; Zhang, B; Zhang, G; Zhang, J; Zhang, K; Zhang, Q; Zhang, R; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, B; Zhao, D; Zhao, G; Zhao, H; Zhao, Q; Zhao, R; Zhao, S; Zhao, T; Zhao, X; Zhao, XA; Zhao, Y; Zhao, Z; Zheng, Z; Zhi-Min, G; Zhou, CL; Zhou, HD; Zhou, J; Zhou, W; Zhou, XQ; Zhou, Z; Zhu, C; Zhu, H; Zhu, L; Zhu, Y; Zitzmann, N; Zou, L; Zou, Y | 1 |
| Airó, P; Andreoli, L; Brucato, A; Colombo, E; Furloni, R; Imazio, M; Piantoni, S; Scarsi, M | 1 |
| Dagna, L; Della-Torre, E; Ramirez, GA; Tresoldi, M | 1 |
| Gasparyan, AY; Misra, DP; Zimba, O | 1 |
| Ahmed, MB; Danjuma, M; El-Bardissy, A; Elshafei, MN; Khalil, A; Mohamed, MFH | 1 |
| Burrage, DR; Koushesh, S; Sofat, N | 1 |
| Lamkanfi, M; Portincasa, P; Stella, A | 1 |
| Bhatt, AS; Bhatt, DL; Blood, A; Jones, WS; Kochar, A; Lopes, RD; Mehra, MR; Monteleone, PP; Patel, MR; Sharkawi, MA; Siddiqi, HK; Vaduganathan, M; Varshney, AS; Wang, DE | 1 |
| Akopyan, ZA; Asratyan, DA; Begrambekova, YL; Kamalov, АА; Malakhov, PS; Mareev, VY; Mareev, YV; Matskeplishvili, ST; Mershina, ЕА; Orlova, YA; Pavlikova, EP; Plisyk, AG; Potapenko, AV; Samokhodskaya, LM; Seredenina, EM; Shatochina, EA; Sinitsyn, VE; Zhdanova, EA | 1 |
| Ackermann, F; Bourguiba, R; Delplanque, M; Georgin-Lavialle, S; Grateau, G; Hentgen, V; Savey, L; Vinit, C | 1 |
| Bandyopadhyay, D; Deedwania, P; Fonarow, GC; Ghosh, RK; Gupta, M; Hajra, A; Kaul, S; Klein, A; Lavie, CJ; Mamas, M; Roddy, E | 1 |
| Airó, P; Andreoli, L; Brucato, A; Colombo, E; Franceschini, F; Furloni, R; Ghirardelli, ML; Imazio, M; Mendeni, M; Piantoni, S; Scarsi, M | 1 |
| Kawada, T | 1 |
| Bartoloni, E; Cafaro, G; Caporali, R; Gerli, R; Perricone, C | 1 |
| Hu, KA; Pillinger, MH; Reyes, AZ; Shah, B; Tardif, JC; Teperman, J; Wampler Muskardin, TL | 1 |
| Almeida, SCL; Alves-Filho, JC; Amaral, NB; Arruda, E; Auxiliadora-Martins, M; Benatti, MN; Bollela, VR; Bonjorno, LP; Borges, MC; Cunha, FQ; Cunha, LD; Cunha, TM; Del-Ben, CM; Dib, SM; Emrich-Filho, LL; Fonseca, BAL; Giannini, MC; Gigante, SL; Leiria, LOS; Lopes, MI; Louzada-Junior, P; Luppino Assad, R; Menezes, PI; Miranda, CH; Oliveira, RDR; Pazin-Filho, A; Rezek, UC; Rodrigues, TS; Santana, RC; Schneider, A; Sousa, BAA; Veras, FP; Vilar, FC; Zamboni, DS | 1 |
| Ferrara, F; Vitiello, A | 1 |
| Féron, F; Gautier, JF; Kevorkian, JP; Lopes, A; Mauvais-Jarvis, F; Mégarbane, B; Mouly, S; Nassarmadji, K; Riveline, JP; Sène, D; Vandiedonck, C | 1 |
| Altaş, A; Eryilmaz, N; Geyik, MF; Nas, K | 1 |
| Mehta, JL; Salah, HM | 1 |
| Anderson, L; Anton-Vazquez, V; Byrne, L; Hamzah, L | 1 |
| Ilias, I; Milionis, C | 1 |
| Eleftheria, K; Eleni, M; Evangelia, M; Evangelos, B; Ioannis, K; Vana, S; Vasilios, V; Vissaria, S | 1 |
| Halim, DA; Hariyanto, TI; Jodhinata, C; Kurniawan, A; Yanto, TA | 1 |
| Al-Gareeb, AI; Al-Kuraishy, HM; Cruz-Martins, N; El-Saber Batiha, G; Qusty, N | 1 |
| Agapov, MA; Akopyan, ZA; Asratyan, DA; Begrambekova, YL; Dyachuk, LI; Kamalov, АА; Krasnova, TN; Malakhov, PS; Mareev, VY; Mareev, YV; Matskeplishvili, ST; Mershina, ЕА; Orlova, YA; Pakhomov, PV; Pavlikova, EP; Plisyk, AG; Potapenko, AV; Samokhodskaya, LM; Seredenina, EM; Sinitsyn, VE; Zhdanova, EA | 1 |
| Antoni, AD; Caminiti, C; Cerundolo, N; Cocchi, E; Cravedi, P; Delsante, M; Donghi, L; Farina, MT; Ferrari, C; Fiaccadori, E; Gandoflini, I; Gentile, M; Maggiore, U; Manenti, L; Meschi, T; Nouvenne, A; Oliva, V; Palmisano, A; Peruzzi, L; Prati, B; Regolisti, G; Riella, LV; Ticinesi, A; Zambrano, C | 1 |
| Hastings, R; Jha, R; Kumar, P; Quek, E; Tahir, H | 1 |
| Ismailos, G; Karalis, V; Karatza, E | 1 |
| Abeles, SR; Jia, S; Kwon, J; Mehta, SR; Nan, B; Watanabe, JH | 1 |
| Altıntaş, D; Ataman, Ş; Baykul, M; Bodur, H; Çay, HF; Cengiz, AK; Çevik, R; Demir, AN; Deveci, H; Duruöz, MT; Ecesoy, H; Günendi, Z; Gürer, G; Karahan, AY; Keskin, Y; Ketenci, S; Melikoğlu, MA; Nas, K; Nayimoğlu, M; Sarıfakıoğlu, AB; Şen, N; Sezer, İ; Toprak, M; Uçar, Ü; Yurdakul, FG; Yurdakul, OV | 1 |
| Asselin, G; Barhdadi, A; Bassevitch, Z; Boivin, G; Bouabdallaoui, N; Busseuil, D; Chabot-Blanchet, M; Chicoine, LM; Choi, J; Cossette, M; de Denus, S; Dedelis, E; Dubé, MP; Dubois, A; Gaudet, D; Goulet, E; Guertin, MC; Hussin, J; L'Allier, PL; Legault, MA; Lemaçon, A; Lemieux Perreault, LP; Lousky, J; Marchand, R; Mongrain, I; Nozza, A; Oussaïd, E; Provost, S; Sandoval, J; Savard, C; Sun, M; Tardif, JC; Valois, D | 1 |
| Audet, S; Bassevitch, Z; Boivin, G; Bouabdallaoui, N; Busque, L; Busseuil, D; Chabot-Blanchet, M; Cossette, M; da Luz, P; Deftereos, SG; Denault, A; Dubé, MP; Dubois, A; Dupuis, J; Fortin, D; Gaudet, D; Goulet, E; Grégoire, JC; Guertin, MC; Hétu, PO; Hsue, P; Joshi, AY; L'Allier, PL; Lacoste, C; Lavallée, C; Lepor, NE; Lesage, F; Levesque, S; Lopez-Sendon, J; Nozza, A; Orfanos, A; Paquette, JS; Pelletier, M; Pillinger, MH; Roy-Clavel, E; Sainturet, N; Samson, S; Shah, B; Stamatescu, G; Tardif, JC; Tardif, JD; Tessier, PA; Verret, L; Waters, DD | 1 |
| Abdeen, S; Abu-Fanne, R; Bdeir, K; Cines, DB; Deshpande, C; Feldman, M; Heyman, SN; Higazi, AA; Higazi, M; Khurram, N; Litzky, LA; Maraga, E; Montone, KT | 1 |
| Drosos, AA; Drossou, V; Pelechas, E; Voulgari, PV | 1 |
| Boyadzhieva, Z; Krusche, M; Ruffer, N | 1 |
| Altorok, N; Assaly, R; Ayesh, H; Beran, A; Ghazaleh, S; Kalifa, M; Mhanna, AS; Mhanna, M; Sajdeya, O; Srour, O; Wahood, W | 1 |
| Abubeker, IY; Danjuma, M; El-Bardissy, A; Elshafei, MN; Khalil, A; Mohamed, MFH; Mubasher, M | 1 |
| Ben-Chetrit, E; Bitan, M; Ishay, Y; Kenig, A; Kharouf, F | 1 |
30 review(s) available for colchicine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Colchicine - From rheumatology to the new kid on the block: Coronary syndromes and COVID-19.
Topics: Colchicine; COVID-19; Familial Mediterranean Fever; Humans; Inflammasomes; Pharyngitis; Rheumatology; Syndrome | 2023 |
Colchicine - new horizons for an ancient drug. Review based on the highest hierarchy of evidence.
Topics: Acute Coronary Syndrome; Colchicine; COVID-19; Humans; Pharmaceutical Preparations; SARS-CoV-2 | 2022 |
Colchicine for the treatment of COVID-19.
Topics: Cause of Death; Colchicine; COVID-19; Humans; Male; Middle Aged; Quality of Life; SARS-CoV-2 | 2021 |
Colchicine, COVID-19 and hematological parameters: A meta-analysis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; C-Reactive Protein; Colchicine; COVID-19; COVID-19 Drug Treatment; Fibrin Fibrinogen Degradation Products; Humans; L-Lactate Dehydrogenase | 2021 |
Can we still consider treatment with colchicine effective in SARS-COV-2 infection? Systematic review, meta-analysis, and trial sequential analysis.
Topics: Adult; Case-Control Studies; Clinical Trials as Topic; Colchicine; COVID-19; COVID-19 Drug Treatment; Critical Care; Hospitalization; Humans; Middle Aged; Mortality; Observational Studies as Topic; Outcome Assessment, Health Care; Randomized Controlled Trials as Topic; Respiration, Artificial; SARS-CoV-2; Sensitivity and Specificity; Treatment Outcome; Tubulin Modulators | 2021 |
Colchicine use in patients with COVID-19: A systematic review and meta-analysis.
Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Colchicine; COVID-19; COVID-19 Drug Treatment; Female; Humans; Intensive Care Units; Male; Middle Aged; Patient Admission; Polymerase Chain Reaction; Respiration, Artificial; Risk; SARS-CoV-2; Treatment Outcome | 2021 |
The effect of colchicine on mortality outcome and duration of hospital stay in patients with COVID-19: A meta-analysis of randomized trials.
Topics: Colchicine; COVID-19; Humans; Length of Stay; Randomized Controlled Trials as Topic; SARS-CoV-2 | 2022 |
Effect of colchicine on mortality in patients with COVID-19 - A systematic review and meta-analysis.
Topics: Aged; Anti-Inflammatory Agents; Colchicine; Comorbidity; COVID-19; COVID-19 Drug Treatment; Diabetes Mellitus; Female; Humans; Hypertension; Male; Middle Aged; Odds Ratio; Randomized Controlled Trials as Topic; SARS-CoV-2; Virus Replication | 2022 |
Colchicine for COVID-19: targeting NLRP3 inflammasome to blunt hyperinflammation.
Topics: Animals; Anti-Inflammatory Agents; Colchicine; COVID-19; COVID-19 Drug Treatment; Humans; Inflammasomes; NLR Family, Pyrin Domain-Containing 3 Protein; SARS-CoV-2 | 2022 |
Colchicine-regeneration of an old drug.
Topics: Cardiovascular Diseases; Colchicine; COVID-19; Humans; Pericarditis; Regeneration | 2023 |
Comparative efficacy and safety of pharmacological interventions for severe COVID-19 patients: An updated network meta-analysis of 48 randomized controlled trials.
Topics: Colchicine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Doxycycline; Humans; Imatinib Mesylate; Immunization, Passive; Immunoglobulins, Intravenous; Interferon beta-1b; Ivermectin; Lopinavir; Methylprednisolone; Network Meta-Analysis; Pandemics; Pneumonia, Viral; Randomized Controlled Trials as Topic; Ritonavir | 2022 |
Pericarditis related to post-acute COVID infection: A case report and review of the literature.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Chest Pain; Colchicine; COVID-19; Female; Humans; Male; Pericarditis | 2023 |
SARS-CoV-2 infection among patients with systemic autoimmune diseases.
Topics: Adrenal Cortex Hormones; Adult; Aged; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Autoimmune Diseases; Betacoronavirus; Colchicine; Coronavirus Infections; COVID-19; Cross-Sectional Studies; Female; Humans; Hydroxychloroquine; Italy; Male; Middle Aged; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Continuous hydroxychloroquine or colchicine therapy does not prevent infection with SARS-CoV-2: Insights from a large healthcare database analysis.
Topics: Adult; Betacoronavirus; Chemoprevention; Colchicine; Coronavirus Infections; COVID-19; Female; Humans; Hydroxychloroquine; Israel; Male; Middle Aged; Pandemics; Pneumonia, Viral; Retrospective Studies; SARS-CoV-2; Treatment Failure | 2020 |
COVID-19: The Potential Role of Copper and N-acetylcysteine (NAC) in a Combination of Candidate Antiviral Treatments Against SARS-CoV-2.
Topics: Acetylcysteine; Adenosine Monophosphate; Adjuvants, Immunologic; Alanine; Anti-Inflammatory Agents; Antiviral Agents; Autophagy; Betacoronavirus; Colchicine; Copper; Coronavirus Infections; COVID-19; Cytidine; Drug Synergism; Drug Therapy, Combination; Humans; Hydroxylamines; Inflammation; Nitric Oxide; Pandemics; Pneumonia, Viral; Prodrugs; Ribonucleosides; SARS-CoV-2; Virus Internalization; Virus Replication | 2020 |
Successful Treatment of Covid-19 Associated Cytokine Release Syndrome with Colchicine. A Case Report and Review of Literature.
Topics: Administration, Oral; Adult; Colchicine; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Gout; Humans; Male; SARS-CoV-2; Treatment Outcome | 2021 |
Anti-inflammatory therapies for pericardial diseases in the COVID-19 pandemic: safety and potentiality.
Topics: Anti-Inflammatory Agents; Betacoronavirus; Colchicine; Comorbidity; Coronavirus Infections; COVID-19; Duration of Therapy; Glucocorticoids; Humans; Inflammation; Interleukin 1 Receptor Antagonist Protein; Pandemics; Pericarditis; Pneumonia, Viral; Receptors, Interleukin-1; SARS-CoV-2 | 2020 |
Review of adverse cutaneous reactions of pharmacologic interventions for COVID-19: A guide for the dermatologist.
Topics: Antimalarials; Antiviral Agents; Betacoronavirus; Colchicine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Diagnosis, Differential; Drug Eruptions; Drug Therapy, Combination; Exanthema; Glucocorticoids; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2; Urticaria | 2020 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea | 2022 |
Benefits and adverse effects of hydroxychloroquine, methotrexate and colchicine: searching for repurposable drug candidates.
Topics: Antirheumatic Agents; Betacoronavirus; Colchicine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Hydroxychloroquine; Methotrexate; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Immunomodulatory Drugs in the Management of SARS-CoV-2.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Colchicine; Coronavirus Infections; COVID-19; Cytokine Release Syndrome; Cytokines; Female; Humans; Hydroxychloroquine; Immunomodulation; Janus Kinase Inhibitors; Middle Aged; Pandemics; Pneumonia, Viral; Risk Factors; SARS-CoV-2; Tumor Necrosis Factor-alpha | 2020 |
Familial Mediterranean Fever and COVID-19: Friends or Foes?
Topics: Animals; Betacoronavirus; C-Reactive Protein; Colchicine; Coronavirus Infections; COVID-19; Familial Mediterranean Fever; Humans; Mutation; Pandemics; Pneumonia, Viral; Pyrin; SARS-CoV-2 | 2020 |
Gout Pharmacotherapy in Cardiovascular Diseases: A Review of Utility and Outcomes.
Topics: Cardiovascular Diseases; Colchicine; COVID-19; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Pandemics | 2021 |
Colchicine and SARS-CoV-2: Management of the hyperinflammatory state.
Topics: Colchicine; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Humans; SARS-CoV-2; Tubulin Modulators | 2021 |
COVID-19 in patients with familial Mediterranean fever treated with colchicine: case based review.
Topics: Adult; Aged; Colchicine; COVID-19; COVID-19 Drug Treatment; Familial Mediterranean Fever; Female; Humans; Interleukin-1; Male; Middle Aged; Prognosis; SARS-CoV-2 | 2021 |
Meta-analysis of the Effect of Colchicine on Mortality and Mechanical Ventilation in COVID-19.
Topics: Colchicine; COVID-19; Global Health; Gout Suppressants; Humans; Pandemics; Respiration, Artificial; SARS-CoV-2; Survival Rate | 2021 |
Colchicine treatment can improve outcomes of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.
Topics: Colchicine; COVID-19; COVID-19 Drug Treatment; Humans; Mortality; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome; Tubulin Modulators | 2021 |
Treatment of COVID-19: a review of current and prospective pharmacotherapies.
Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; Anticoagulants; Antiviral Agents; Azetidines; Colchicine; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Dexamethasone; Glucocorticoids; Humans; Immunization, Passive; Immunologic Factors; Ivermectin; Janus Kinase Inhibitors; Platelet Aggregation Inhibitors; Purines; Pyrazoles; SARS-CoV-2; Sulfonamides | 2021 |
COVID-19 in patients with gout on colchicine.
Topics: Anti-Inflammatory Agents; Colchicine; COVID-19; Cytokines; Gout; Host-Pathogen Interactions; Humans; Inflammation Mediators; Male; Middle Aged; SARS-CoV-2 | 2021 |
Colchicine use might be associated with lower mortality in COVID-19 patients: A meta-analysis.
Topics: Colchicine; COVID-19; COVID-19 Drug Treatment; Humans; Odds Ratio; SARS-CoV-2; Tubulin Modulators | 2021 |
26 trial(s) available for colchicine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Design and rationale of the colchicine/statin for the prevention of COVID-19 complications (COLSTAT) trial.
Topics: Colchicine; COVID-19; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; SARS-CoV-2; Treatment Outcome | 2021 |
The effectiveness of early colchicine administration in patients over 60 years old with high risk of developing severe pulmonary complications associated with coronavirus pneumonia SARS-CoV-2 (COVID-19): study protocol for an investigator-driven randomize
Topics: Aged; Colchicine; COVID-19; Humans; Middle Aged; Multicenter Studies as Topic; Pandemics; Primary Health Care; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome | 2021 |
Divergent impacts of tocilizumab and colchicine in COVID-19-associated coagulopathy: the role of alpha-defensins.
Topics: Aged; alpha-Defensins; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Blood Coagulation; Colchicine; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Female; Fibrin Fibrinogen Degradation Products; Humans; Interleukin-6; Male; Middle Aged; Neutrophils | 2022 |
Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Topics: Adult; Colchicine; COVID-19; COVID-19 Drug Treatment; Hospitalization; Humans; Indonesia; Length of Stay; Nepal; Respiration, Artificial; SARS-CoV-2; United Kingdom | 2021 |
Effect of Colchicine vs Usual Care Alone on Intubation and 28-Day Mortality in Patients Hospitalized With COVID-19: A Randomized Clinical Trial.
Topics: Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents; Colchicine; COVID-19; Female; Hospitalization; Humans; Inflammation; Intubation, Intratracheal; Male; Middle Aged; Respiration, Artificial; SARS-CoV-2; Standard of Care | 2021 |
Efficacy and safety of colchicine treatment in patients with COVID-19: A prospective, multicenter, randomized clinical trial.
Topics: Colchicine; COVID-19; Humans; Male; Middle Aged; Prospective Studies; SARS-CoV-2; Treatment Outcome | 2022 |
Efficacy of short-course colchicine treatment in hospitalized patients with moderate to severe COVID-19 pneumonia and hyperinflammation: a randomized clinical trial.
Topics: Adult; Colchicine; COVID-19; COVID-19 Drug Treatment; Humans; Intensive Care Units; Prospective Studies; Respiration, Artificial | 2022 |
Colchicine and aspirin in community patients with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial.
Topics: Aspirin; Canada; Colchicine; COVID-19; Disease Progression; Humans; SARS-CoV-2; Thrombosis; Treatment Outcome | 2022 |
Treatment with COLchicine in hospitalized patients affected by COVID-19: The COLVID-19 trial.
Topics: Aged; Aged, 80 and over; Colchicine; COVID-19; Female; Humans; Male; Middle Aged; Patient Discharge; SARS-CoV-2; Treatment Outcome | 2023 |
Proactive anti-inflammatory therapy in the advanced stages of a new coronavirus infection. Main results of the inpatient phase of the COLORIT study (Colchicin vs. Ruxolitinib and secukinumab in an open, prospective, randomized trial in patients with novel
Topics: Anti-Inflammatory Agents; Colchicine; COVID-19; Cytokines; Humans; Inflammation; Inpatients; Prospective Studies; RNA, Viral; SARS-CoV-2; Treatment Outcome | 2022 |
The effects of colchicine on hospitalized COVID-19 patients: A randomized, double-blind, placebo-controlled clinical trial.
Topics: Adult; Colchicine; COVID-19; Double-Blind Method; Hospitalization; Humans; Prospective Studies; SARS-CoV-2; Treatment Outcome | 2023 |
In high-risk outpatients with COVID-19, neither colchicine nor aspirin reduced disease progression or death at 45 d.
Topics: Aspirin; Colchicine; COVID-19; Disease Progression; Humans; Outpatients; Treatment Outcome | 2023 |
Colchicine and high-intensity rosuvastatin in the treatment of non-critically ill patients hospitalised with COVID-19: a randomised clinical trial.
Topics: Brain Ischemia; Colchicine; COVID-19; Female; Humans; Male; Middle Aged; Rosuvastatin Calcium; SARS-CoV-2; Stroke; Treatment Outcome | 2023 |
Colchicine reduces the activation of NLRP3 inflammasome in COVID-19 patients.
Topics: Colchicine; COVID-19; Humans; Inflammasomes; Interleukin-18; Interleukin-1beta; NLR Family, Pyrin Domain-Containing 3 Protein; NLR Proteins | 2023 |
Efficacy and safety of Ixekizumab vs. low-dose IL-2 vs. Colchicine vs. standard of care in the treatment of patients hospitalized with moderate-to-critical COVID-19: A pilot randomized clinical trial (STRUCK: Survival Trial Using Cytokine Inhibitors).
Topics: Colchicine; COVID-19; COVID-19 Drug Treatment; Cytokines; Humans; Interleukin-17; Interleukin-2; Pilot Projects; Prospective Studies; SARS-CoV-2; Standard of Care; Treatment Outcome | 2023 |
Edoxaban and/or colchicine in outpatients with COVID-19: rationale and design of the CONVINCE trial.
Topics: Adult; Anti-Inflammatory Agents; Anticoagulants; Colchicine; COVID-19; Humans; Infant, Newborn; Outpatients; SARS-CoV-2; Treatment Outcome | 2023 |
Colchicine's effects on metabolic and inflammatory molecules in adults with obesity and metabolic syndrome: results from a pilot randomized controlled trial.
Topics: Adult; Anti-Inflammatory Agents; Betacoronavirus; C-Reactive Protein; Colchicine; Coronavirus Infections; COVID-19; Double-Blind Method; Female; Humans; Interleukin-6; Male; Metabolic Syndrome; Middle Aged; Obesity; Pandemics; Pilot Projects; Pneumonia, Viral; SARS-CoV-2; Treatment Outcome; Young Adult | 2020 |
Adding Colchicine to the Antiretroviral Medication - Lopinavir/Ritonavir (Kaletra) in Hospitalized Patients with Non-Severe Covid-19 Pneumonia: A Structured Summary of a Study Protocol for a Randomized Controlled Trial.
Topics: Betacoronavirus; Colchicine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Double-Blind Method; Drug Combinations; Hospitalization; Humans; Lopinavir; Pandemics; Pneumonia, Viral; Prospective Studies; Randomized Controlled Trials as Topic; Ritonavir; SARS-CoV-2 | 2020 |
Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019: The GRECCO-19 Randomized Clinical Trial.
Topics: Aged; Aged, 80 and over; Betacoronavirus; C-Reactive Protein; Cause of Death; Colchicine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Diarrhea; Disease Progression; Female; Fibrin Fibrinogen Degradation Products; Greece; Hospitalization; Humans; Inflammation; Kaplan-Meier Estimate; Male; Middle Aged; Mortality; Pandemics; Pneumonia, Viral; Respiration, Artificial; SARS-CoV-2; Time Factors; Treatment Outcome; Troponin; Tubulin Modulators | 2020 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea | 2022 |
[Proactive anti-inflammatory and anticoagulant therapy in the treatment of advanced stages of novel coronavirus infection (COVID-19). Case Series and Study Design: COLchicine versus ruxolitinib and secukinumab in open prospective randomIzed trial (COLORIT
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Anticoagulants; Betacoronavirus; Colchicine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Nitriles; Pandemics; Pneumonia, Viral; Prospective Studies; Pyrazoles; Pyrimidines; SARS-CoV-2 | 2020 |
Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trial.
Topics: Adult; Aged; Colchicine; COVID-19; COVID-19 Drug Treatment; Diarrhea; Double-Blind Method; Female; Humans; Intensive Care Units; Length of Stay; Male; Middle Aged; Oxygen Inhalation Therapy; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Severity of Illness Index; Time Factors; Treatment Outcome | 2021 |
Proactive anti-inflammatory therapy with colchicine in the treatment of advanced stages of new coronavirus infection. The first results of the COLORIT study.
Topics: Anti-Inflammatory Agents; Colchicine; Coronavirus Infections; COVID-19; Humans; Prospective Studies; SARS-CoV-2; Treatment Outcome | 2021 |
Genetics of symptom remission in outpatients with COVID-19.
Topics: Adult; Chromosomes, Human, Pair 5; Chromosomes, Human, Pair 9; Colchicine; COVID-19; COVID-19 Drug Treatment; Double-Blind Method; Female; Gene Frequency; Genome-Wide Association Study; Genotype; Humans; Male; Middle Aged; Outpatients; Placebo Effect; Proportional Hazards Models; Remission Induction; Risk Factors; SARS-CoV-2; Severity of Illness Index | 2021 |
Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial.
Topics: Administration, Oral; Ambulatory Care; Anti-Inflammatory Agents; Colchicine; COVID-19; COVID-19 Drug Treatment; Double-Blind Method; Drug Monitoring; Female; Hospitalization; Humans; Intention to Treat Analysis; Male; Middle Aged; Outcome Assessment, Health Care; Risk Assessment; SARS-CoV-2 | 2021 |
Alpha-defensins: risk factor for thrombosis in COVID-19 infection.
Topics: Adult; Aged; alpha-Defensins; Animals; Blood Coagulation; Case-Control Studies; Colchicine; COVID-19; Female; Fibrin Fibrinogen Degradation Products; Humans; Inflammation; Interleukin-6; Male; Mice; Middle Aged; Models, Animal; Neutrophils; Prospective Studies; Risk Factors; SARS-CoV-2; Severity of Illness Index; Thromboembolism; Thrombosis; Tubulin Modulators | 2021 |
68 other study(ies) available for colchicine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Clinical outcome of patients with COVID-19 Pneumonia treated with corticosteroids and colchicine in Colombia.
Topics: Adrenal Cortex Hormones; Adult; Aged; Colchicine; Colombia; COVID-19; COVID-19 Drug Treatment; COVID-19 Nucleic Acid Testing; Cross-Sectional Studies; Female; Hospitalization; Humans; Male; Middle Aged; RNA, Viral; SARS-CoV-2; Treatment Outcome | 2021 |
Colchicine treatment in COVID-19: the remaining unsolved question.
Topics: Colchicine; COVID-19; Humans; SARS-CoV-2; Treatment Outcome | 2021 |
Pericarditis after SARS-CoV-2 Infection: Another Pebble in the Mosaic of Long COVID?
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Colchicine; COVID-19; COVID-19 Drug Treatment; Female; Glucocorticoids; Humans; Male; Middle Aged; Pericardial Effusion; Pericarditis; Pericardium; Post-Acute COVID-19 Syndrome; SARS-CoV-2 | 2021 |
Colchicine, fragmented QRS, coronavirus disease 2019, and more.
Topics: Colchicine; COVID-19; Electrocardiography; Humans; SARS-CoV-2 | 2021 |
Efficacy and safety of colchicine in COVID-19: a meta-analysis of randomised controlled trials.
Topics: Colchicine; COVID-19; Humans; SARS-CoV-2 | 2021 |
Colchicine for the prevention of COVID-19 "hard" outcomes: All that glitters is not gold.
Topics: Colchicine; COVID-19; Humans; SARS-CoV-2 | 2022 |
Clinical course of COVID-19 infection in paediatric familial Mediterranean fever patients.
Topics: Child; Colchicine; COVID-19; Familial Mediterranean Fever; Humans; SARS-CoV-2 | 2022 |
Generation of Spike-Extracellular Vesicles (S-EVs) as a Tool to Mimic SARS-CoV-2 Interaction with Host Cells.
Topics: Angiotensin-Converting Enzyme 2; Antibodies, Blocking; Cell Line; Cells, Cultured; Colchicine; COVID-19; Extracellular Vesicles; Flow Cytometry; HEK293 Cells; Host Microbial Interactions; Human Umbilical Vein Endothelial Cells; Humans; Microscopy, Fluorescence; Protein Binding; SARS-CoV-2; Spike Glycoprotein, Coronavirus | 2022 |
Pericarditis as a Secondary Complication of COVID-19 in a Renal Transplant Patient.
Topics: Aged; Colchicine; COVID-19; Female; Humans; Kidney Transplantation; Pericarditis; SARS-CoV-2 | 2021 |
Clinical course of Covid-19 in a cohort of patients with Behçet disease.
Topics: Adult; Behcet Syndrome; Colchicine; COVID-19; Dyspnea; Female; Glucocorticoids; Humans; Male; Middle Aged; Retrospective Studies; Tumor Necrosis Factor Inhibitors | 2022 |
COVID-19 presenting as acute pericarditis.
Topics: Colchicine; COVID-19; Humans; Male; Pandemics; Pericarditis; SARS-CoV-2 | 2022 |
Colchicine in the management of Covid-19: With or lieu of evidence.
Topics: Anti-Inflammatory Agents; Colchicine; COVID-19; Cytokine Release Syndrome; Cytokines; Humans; SARS-CoV-2 | 2021 |
Mechanism of Caspase-1 Inhibition by Four Anti-inflammatory Drugs Used in COVID-19 Treatment.
Topics: Anti-Inflammatory Agents; Caspase 1; Caspase Inhibitors; Colchicine; Coronavirus 3C Proteases; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Humans; Models, Molecular; Molecular Docking Simulation; Pentacyclic Triterpenes; Protein Interaction Domains and Motifs; Raloxifene Hydrochloride; Viral Protease Inhibitors | 2022 |
Reducing length of hospital stay with colchicine.
Topics: Colchicine; COVID-19; Hospitalization; Humans; Intensive Care Units; Length of Stay; Retrospective Studies; SARS-CoV-2 | 2022 |
Colchicine prophylaxis is associated with fewer gout flares after COVID-19 vaccination.
Topics: Adult; Colchicine; COVID-19; COVID-19 Vaccines; Cross-Sectional Studies; Gout; Gout Suppressants; Humans; Symptom Flare Up; Vaccination; Vaccines | 2022 |
A single-center COVID-19 vaccine experience with CoronaVac and BNT162b2 in familial Mediterranean fever patients.
Topics: BNT162 Vaccine; Colchicine; COVID-19; COVID-19 Vaccines; Familial Mediterranean Fever; Humans | 2022 |
Rural treatment of COVID-19 patients with pirfenidone, nitazoxanide and colchicine. Case series.
Topics: Adult; Colchicine; COVID-19; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; SARS-CoV-2 | 2022 |
Clinical impact and disease evolution of SARS-CoV-2 infection in familial Mediterranean fever.
Topics: Colchicine; COVID-19; COVID-19 Vaccines; Familial Mediterranean Fever; Humans; SARS-CoV-2 | 2022 |
Changes in dispensing of medicines proposed for re-purposing in the first year of the COVID-19 pandemic in Australia.
Topics: Azithromycin; Calcitriol; Colchicine; COVID-19; COVID-19 Drug Treatment; Cross-Sectional Studies; Humans; Hydroxychloroquine; Ivermectin; Pandemics | 2022 |
Pericarditis complicating COVID-19 infection: a report of two cases.
Topics: Colchicine; COVID-19; Humans; Pericarditis; SARS-CoV-2 | 2022 |
COVID-19 in familial Mediterranean fever: Clinical course and complications related to primary disease.
Topics: Arthritis; Colchicine; COVID-19; Disease Progression; Familial Mediterranean Fever; Female; Fever; Humans; Male | 2023 |
[Immunotherapy with anti-SARS-COV-2 neutralizing F(ab')2 antibodies from equine serum in the treatment of outpatients with bilateral COVID-19 pneumonia].
Topics: Animals; Antibodies, Neutralizing; Antibodies, Viral; Colchicine; COVID-19; COVID-19 Vaccines; Horses; Humans; Immunologic Factors; Immunotherapy; Outpatients; Retrospective Studies; SARS-CoV-2 | 2022 |
Evaluating of colchicine use patterns and attack frequency of familial Mediterranean fever patients in the COVID-19 pandemic.
Topics: Case-Control Studies; Colchicine; COVID-19; Familial Mediterranean Fever; Humans; Pandemics | 2023 |
Letter to the Editor: There Is No Indication for Treating Long COVID Vaccination Syndrome With Colchicine.
Topics: Adult; Colchicine; COVID-19; Humans; Post-Acute COVID-19 Syndrome; RNA, Messenger; Vaccination | 2022 |
Colchicine and risk of hospitalization due to COVID-19: A population-based study.
Topics: Case-Control Studies; Colchicine; COVID-19; Hospitalization; Humans; SARS-CoV-2 | 2023 |
Colchicine and mortality outcomes in patients with coronavirus disease (COVID-19).
Topics: Colchicine; COVID-19; Humans; SARS-CoV-2 | 2023 |
Colchicine and risk of COVID-19-associated hospitalization.
Topics: Colchicine; COVID-19; Hospitalization; Humans; SARS-CoV-2 | 2023 |
RE: Colchicine and risk of hospitalization due to COVID-19: A population-based study.
Topics: Colchicine; COVID-19; Hospitalization; Humans; Research; SARS-CoV-2 | 2023 |
Colchicine for the treatment of COVID-19.
Topics: Colchicine; COVID-19; Humans; SARS-CoV-2 | 2023 |
Relapse of colchicine-intolerant, corticosteroid-dependent recurrent idiopathic pericarditis after perigestational discontinuation of anakinra: uncertain safety of anakinra in pregnancy and the need for shared decision-making.
Topics: Adrenal Cortex Hormones; Chronic Disease; Colchicine; COVID-19; Female; Humans; Infant, Newborn; Interleukin 1 Receptor Antagonist Protein; Pericarditis; Pregnancy; Recurrence | 2023 |
COVID-19 in kidney transplant recipients.
Topics: Aged; Betacoronavirus; Cobicistat; Colchicine; Coronavirus Infections; COVID-19; Cytokines; Darunavir; Drug Combinations; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Lopinavir; Male; Middle Aged; Mycophenolic Acid; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2; Tacrolimus; Transplant Recipients; Treatment Outcome | 2020 |
Colchicine as a potent anti-inflammatory treatment in COVID-19: can we teach an old dog new tricks?
Topics: Betacoronavirus; Colchicine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Inflammasomes; Ion Channels; Pandemics; Pneumonia, Viral; SARS-CoV-2; Tubulin Modulators; Viral Nonstructural Proteins; Viroporin Proteins | 2020 |
Dapsone, colchicine and olanzapine as treatment adjuncts to prevent COVID-19 associated adult respiratory distress syndrome (ARDS).
Topics: Adult; Betacoronavirus; Chemotaxis, Leukocyte; Colchicine; Coronavirus Infections; COVID-19; Dapsone; Humans; Interleukin-8; Neutrophils; Olanzapine; Pandemics; Pneumonia, Viral; Respiratory Distress Syndrome; SARS-CoV-2 | 2020 |
Colchicine may not be effective in COVID-19 infection; it may even be harmful?
Topics: Alveolar Epithelial Cells; Betacoronavirus; Colchicine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Disseminated Intravascular Coagulation; Humans; Multiple Organ Failure; Pandemics; Pneumonia, Viral; Pulmonary Surfactants; Respiratory Distress Syndrome; SARS-CoV-2; Tubulin Modulators | 2020 |
Can Colchicine as an Old Anti-Inflammatory Agent Be Effective in COVID-19?
Topics: Anti-Inflammatory Agents; Betacoronavirus; Colchicine; Coronavirus Infections; COVID-19; Cytokines; Humans; Inflammation Mediators; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Why not to use colchicine in COVID-19? An oldanti-inflammatory drug for a novel auto-inflammatory disease.
Topics: Betacoronavirus; Colchicine; Coronavirus Infections; COVID-19; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Treating COVID-19 with colchicine in community healthcare setting.
Topics: Acetaminophen; Anti-Inflammatory Agents; Azithromycin; Betacoronavirus; Cohort Studies; Colchicine; Community Health Services; Coronavirus Infections; COVID-19; Cytokine Release Syndrome; Fever; Gene Expression; Humans; Immunity, Innate; Inflammasomes; Intensive Care Units; Interleukin-1; Interleukin-6; Italy; Pandemics; Pneumonia, Viral; SARS-CoV-2; Severe Acute Respiratory Syndrome; Time Factors | 2020 |
COVID-19 infection in a patient with FMF: does colchicine have a protective effect?
Topics: Antirheumatic Agents; Colchicine; COVID-19; Familial Mediterranean Fever; Humans | 2021 |
Candidate rheumatologic treatments for COVID-19. Response to: 'COVID-19 infection in a patient with FMF: does colchicine have a protective effect?' by Kobak.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Colchicine; COVID-19; Familial Mediterranean Fever; Humans | 2021 |
Colchicine and COVID-19.
Topics: Anti-Inflammatory Agents; Betacoronavirus; Colchicine; Coronavirus Infections; COVID-19; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Colchicine as a possible therapeutic option in COVID-19 infection.
Topics: Betacoronavirus; Colchicine; Coronavirus Infections; COVID-19; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Comment on "Colchicine may not be effective in COVID-19 infection; it may even be harmful?"
Topics: Betacoronavirus; Colchicine; Coronavirus Infections; COVID-19; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
The rationale for the use of colchicine in COVID-19: comments on the letter by Cumhur Cure M et al.
Topics: Betacoronavirus; Colchicine; Coronavirus Infections; COVID-19; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Colchicine for the Treatment of Myocardial Injury in Patients With Coronavirus Disease 2019 (COVID-19)-An Old Drug With New Life?
Topics: Betacoronavirus; Biomarkers; Colchicine; Coronavirus; Coronavirus Infections; COVID-19; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Colchicin treatment of COVID-19 presenting with cutaneous rash and myopericarditis.
Topics: Anti-Inflammatory Agents; Colchicine; COVID-19; COVID-19 Drug Treatment; Exanthema; Female; Humans; Pericarditis; Skin Diseases, Viral; Treatment Outcome; Young Adult | 2020 |
Management of childhood-onset autoinflammatory diseases during the COVID-19 pandemic.
Topics: Adalimumab; Adolescent; Antibodies, Monoclonal, Humanized; Betacoronavirus; Biological Products; Child; Child, Preschool; Cohort Studies; Colchicine; Coronavirus Infections; COVID-19; Cryopyrin-Associated Periodic Syndromes; Etanercept; Familial Mediterranean Fever; Female; Hereditary Autoinflammatory Diseases; Humans; Infant; Interleukin 1 Receptor Antagonist Protein; Male; Pandemics; Pneumonia, Viral; SARS-CoV-2; Tubulin Modulators; Tumor Necrosis Factor Inhibitors; Turkey; Young Adult | 2020 |
Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antiviral Agents; Betacoronavirus; Case-Control Studies; Cohort Studies; Colchicine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Drug Combinations; Enzyme Inhibitors; Female; Hospitalization; Humans; Hydroxychloroquine; Italy; Lopinavir; Male; Middle Aged; Pandemics; Pneumonia, Viral; Proof of Concept Study; Proportional Hazards Models; Respiratory Distress Syndrome; Ritonavir; SARS-CoV-2; Survival Rate | 2020 |
Anti-inflammatory action of colchicine in hospitalised patients with COVID-19. Response to: 'Colchicine treatment in community healthcare setting to prevent severe COVID-19' by Della-Torre
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Colchicine; Community Health Services; COVID-19; Humans | 2022 |
Colchicine treatment in community healthcare setting to prevent severe COVID-19.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Colchicine; Community Health Services; COVID-19; Humans | 2022 |
The efficacy of colchicine in the management of coronavirus disease 2019: A protocol for systematic review and meta-analysis.
Topics: Anti-Inflammatory Agents; Betacoronavirus; Colchicine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Meta-Analysis as Topic; Pandemics; Pneumonia, Viral; Randomized Controlled Trials as Topic; Research Design; SARS-CoV-2; Systematic Review as Topic | 2020 |
Characteristics of clinical trials evaluating cardiovascular therapies for Coronavirus Disease 2019 Registered on ClinicalTrials.gov: a cross sectional analysis.
Topics: Cardiovascular Agents; Cardiovascular Diseases; Clinical Trials as Topic; Colchicine; Combined Modality Therapy; COVID-19; COVID-19 Drug Treatment; Databases, Factual; Extracorporeal Membrane Oxygenation; Fibrinolytic Agents; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; National Library of Medicine (U.S.); Patient Participation; Randomized Controlled Trials as Topic; Registries; Renin-Angiotensin System; SARS-CoV-2; Treatment Outcome; United States; Vasodilator Agents | 2021 |
Clinical course of COVID-19 in a cohort of 342 familial Mediterranean fever patients with a long-term treatment by colchicine in a French endemic area.
Topics: Amyloidosis; Cohort Studies; Colchicine; COVID-19; Familial Mediterranean Fever; Humans | 2021 |
Response to: 'Correspondence on 'Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome'' by Kawada.
Topics: Adult; Colchicine; COVID-19; Humans; Respiratory Distress Syndrome; SARS-CoV-2 | 2023 |
Correspondence on 'Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome'.
Topics: Adult; Colchicine; COVID-19; Humans; Respiratory Distress Syndrome; SARS-CoV-2 | 2023 |
Correspondence on 'Anti-inflammatory therapy for COVID-19 infection: the case for colchicine'.
Topics: Anti-Inflammatory Agents; Colchicine; COVID-19; Gout; Gout Suppressants; Humans | 2023 |
Response to: 'Correspondence on 'Anti-inflammatory therapy for COVID-19 infection: the case for colchicine'' by Perricone
Topics: Anti-Inflammatory Agents; Colchicine; COVID-19; Humans; SARS-CoV-2 | 2023 |
Oral corticoid, aspirin, anticoagulant, colchicine, and furosemide to improve the outcome of hospitalized COVID-19 patients - the COCAA-COLA cohort study.
Topics: Adrenal Cortex Hormones; Anticoagulants; Aspirin; Cohort Studies; Colchicine; COVID-19; Furosemide; Humans; SARS-CoV-2; Treatment Outcome | 2021 |
COVID-19 cardiac injury and the use of colchicine.
Topics: Chest Pain; Colchicine; COVID-19; COVID-19 Drug Treatment; Echocardiography; Heart Diseases; Humans; Male; Middle Aged; Myocardium; Natriuretic Peptide, Brain; Peptide Fragments; Systole; Troponin T | 2021 |
COVID-19, colchicine and glycemia.
Topics: Blood Glucose; Colchicine; COVID-19; COVID-19 Drug Treatment; Hospitalization; Humans; Hyperglycemia; Hypoglycemia; Models, Theoretical; Respiration, Artificial | 2021 |
Clinical features and outcomes of hospitalized COVID-19 patients in a low burden region.
Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Adult; Aged; Alanine; Anti-Bacterial Agents; Antimalarials; Antiviral Agents; Azithromycin; Colchicine; COVID-19; Drug Therapy, Combination; Female; Greece; Hospitalization; Humans; Hydroxychloroquine; Male; Middle Aged; Retrospective Studies; SARS-CoV-2; Treatment Outcome; Young Adult | 2021 |
Sequential doxycycline and colchicine combination therapy in Covid-19: The salutary effects.
Topics: Adult; Aged; Colchicine; COVID-19; COVID-19 Drug Treatment; Doxycycline; Drug Combinations; Female; Humans; Male; Middle Aged; Pandemics; SARS-CoV-2 | 2021 |
Reduced mortality in COVID-19 patients treated with colchicine: Results from a retrospective, observational study.
Topics: Aged; Aged, 80 and over; Colchicine; COVID-19; COVID-19 Drug Treatment; Female; Hospitalization; Humans; Male; Middle Aged; Retrospective Studies; SARS-CoV-2; Treatment Outcome | 2021 |
Colchicine for the treatment of COVID-19 patients: efficacy, safety, and model informed dosage regimens.
Topics: Colchicine; COVID-19; Drug Interactions; Humans; Plasma; SARS-CoV-2 | 2021 |
Medication Use Patterns in Hospitalized Patients With COVID-19 in California During the Pandemic.
Topics: Adenosine Monophosphate; Adult; Alanine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Bacterial Agents; Anti-Inflammatory Agents; Anticoagulants; Antiviral Agents; Azithromycin; California; Colchicine; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Drug Therapy, Combination; Drug Utilization Review; Female; Hospitalization; Humans; Hydrocortisone; Hydroxychloroquine; Male; Pandemics; SARS-CoV-2 | 2021 |
The impact of COVID-19 on familial Mediterranean fever: a nationwide study.
Topics: Adult; Colchicine; COVID-19; Cross-Sectional Studies; Databases, Factual; Familial Mediterranean Fever; Female; Hospitalization; Host-Pathogen Interactions; Humans; Male; Middle Aged; Prognosis; SARS-CoV-2; Severity of Illness Index; Turkey; Young Adult | 2021 |
[Colchicine: old medication with new benefits : Use in rheumatology and beyond].
Topics: Colchicine; COVID-19; Familial Mediterranean Fever; Humans; Rheumatology; SARS-CoV-2 | 2021 |
Colchicine Treatment in SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis.
Topics: Colchicine; COVID-19; Humans; SARS-CoV-2 | 2021 |
Incidence and course of COVID-19 hospitalizations among patients with familial Mediterranean fever.
Topics: Adolescent; Adult; Aged; Case-Control Studies; Colchicine; COVID-19; Familial Mediterranean Fever; Female; Hospitalization; Humans; Incidence; Israel; Male; Middle Aged; SARS-CoV-2; Severity of Illness Index; Young Adult | 2021 |